Nanoparticles give immune cells a boost
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
Search Stories
3Q: Nancy Hopkins on the impact and potential of cancer prevention
Mechanism-based cancer prevention is poised to further decrease the numbers of U.S. cancer deaths, says MIT professor emerita.
Over the river and do some good
The Bridge Project collaboration accelerates new, highly original, and powerful approaches to defeating cancer.
Fast, noninvasive technique for probing cells may reveal disease
Researchers gauge a cell’s stiffness, which can reflect cancer or other conditions, simply by watching it.
Department of Biology welcomes three new faculty members
Recent additions bring diverse expertise and cultural perspectives to research community.
Fighting cancer with the power of immunity
New treatment elicits two-pronged immune response that destroys tumors in mice.
Taking on melanoma, one cell at a time
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
Why some tumors withstand treatment
Researchers uncover a mechanism that allows cancer cells to evade targeted therapies.
How to identify drugs that work best for each patient
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
Recruiting the entire immune system to attack cancer
Stimulating both major branches of the immune system halts tumor growth more effectively.
From the heart
Laurie Boyer’s studies of stem cell differentiation could improve treatments for heart disease.
Forbes hails MIT standouts in science, education, energy, technology, and health care
11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.
A health and fitness tracker for dogs
FitBark, founded by MIT Sloan alumnus Davide Rossi, will monitor your dog’s health and activity every day.
Hitchhiking vaccines boost immunity
New MIT vaccines that catch a ride to immune cell depots could help fight cancer and HIV.